IDVOther than small business
IDC (single-award IDV) HHSF223201610004IBIOPHARMA SERVICES USA
Overview
Award facts
- Obligated on orders under this IDV
- $8.51M
- $8,514,505 across 4 orders
- Period of performance
- From Feb 11, 2016
- Modifications
- 5
- Latest action Aug 4, 2020
- Contract type
- IDC (single-award IDV)
- PIID HHSF223201610004I
Description of requirement
IGF::OT::IGF - IDIQ CONTRACT ENTITLED "VIVO STUDY OF GENERIC DRUG PRODUCTS IN HUMAN SUBJECTS".
Dates and value
- Award date
- Signed on Feb 11, 2016
- Ordering period ends
- May 15, 2021
- Ceiling
- Ceiling (single-award vehicle): $20,000,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 4, 2020. View on USAspending · Recipient on SAM.gov
Recipient
LocationCOLUMBIA, MO
UEIDRLXCANKKNN6
CAGE code7G0A9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBIOPHARMA SERVICES USA
Business types and certifications
Foreign-ownedFor-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
Classification and competition
Classification
- Product or service (PSC)
- B528SPECIAL STUDIES/ANALYSIS- REGULATORY (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 4
Solicitation and notices
- Solicitation ID
- FDASOL1146520(as reported)
Contract details
- Subcontracting plan
- Commercial subcontract planG
- Major program
- In vivo study of generic drug products in human subjects
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Feb 11, 2016Base obligation at award: $2,500
- Latest action
- Aug 4, 2020 — Other administrative actionModification P00005; administrative: no change in scope or value
- Latest substantive action
- Aug 4, 2020 — Option exercisedModification P00004
- Actions by type
- Base award1
- Option exercised4
- Other administrative action1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / indefinite quantityB
- Multiple or single award
- Single awardS
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 6
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401